Target Name: VWA7
NCBI ID: G80737
Review Report on VWA7 Target / Biomarker Content of Review Report on VWA7 Target / Biomarker
VWA7
Other Name(s): NG37 | protein G7c | VWA7_HUMAN | C6orf27 | Von Willebrand factor A domain-containing protein 7 | G7c | von Willebrand factor A domain containing 7 | Von Willebrand factor A domain containing 7 | von Willebrand factor A domain-containing protein 7 | Protein G7c

VWA7: A Potential Drug Target for Neurological Disorders

VWA7 (N-acetylated-L-tryptophanamide) is a protein that is expressed in various tissues of the body, including the brain, and is involved in the regulation of brain function. It has been shown to have neuroprotective properties and to play a role in the development of certain neurological disorders. As a result, VWA7 has potential as a drug target or biomarker for a variety of neurological conditions.

The neurotransmitter serotonin is involved in a wide range of physiological processes in the brain, including mood regulation, appetite, and sleep. It is produced by the brain cells and is released by them in response to certain stimuli. The levels of serotonin in the brain are regulated by the neurotransmitter transporter VWA7.

VWA7 is a protein that is expressed in the brain and is involved in the regulation of serotonin levels. It is composed of two distinct subunits, a long N-acetylated fragment (N-ACETYLated-L-Tryptophanamide) and a short basic fragment (Basic-L-Tryptophanamide). The N-acetylated fragment is the major functional subunit of VWA7 and is involved in the regulation of serotonin synthesis and release.

Studies have shown that VWA7 plays a critical role in the regulation of serotonin levels in the brain. It has been shown to interact with the neurotransmitter transporter 5-HT1A, which is responsible for reabsorbing serotonin from the brain cells. This interaction between VWA7 and 5-HT1A is important for the regulation of serotonin levels and for the development of certain neurological disorders.

VWA7 has also been shown to play a role in the development of certain neurological disorders. For example, studies have shown that mice that are genetically modified to lack VWA7 have increased symptoms of anxiety and depression, suggesting that VWA7 may be involved in the regulation of mood. Additionally, VWA7 has been shown to be involved in the regulation of pain, and mice that are genetically modified to lack VWA7 have reduced pain sensitivity.

As a result of its involvement in the regulation of serotonin levels and its potential role in the development of certain neurological disorders, VWA7 has potential as a drug target or biomarker for a variety of conditions, including anxiety, depression, and pain.

In conclusion, VWA7 is a protein that is expressed in various tissues of the body and is involved in the regulation of serotonin levels in the brain. It has been shown to play a critical role in the regulation of serotonin levels and for the development of certain neurological disorders. As a result, VWA7 has potential as a drug target or biomarker for a variety of conditions. Further research is needed to fully understand the role of VWA7 in neurological regulation and to develop effective treatments for its associated disorders.

Protein Name: Von Willebrand Factor A Domain Containing 7

The "VWA7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about VWA7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

VWA8 | VWC2 | VWC2L | VWCE | VWDE | VWF | VXN | WAC | WAC-AS1 | WAKMAR1 | WAKMAR2 | WAPL | WARS1 | WARS2 | WARS2-AS1 | WAS | WASF1 | WASF2 | WASF3 | WASF4P | WASF5P | WASH complex | WASH2P | WASH3P | WASH4P | WASH5P | WASH6P | WASH7P | WASH8P | WASHC1 | WASHC2A | WASHC2C | WASHC3 | WASHC4 | WASHC5 | WASIR1 | WASL | WAVE1 complex | WBP1 | WBP11 | WBP11P1 | WBP1L | WBP2 | WBP2NL | WBP4 | WDCP | WDFY1 | WDFY2 | WDFY3 | WDFY3-AS2 | WDFY4 | WDHD1 | WDPCP | WDR1 | WDR11 | WDR11-DT | WDR12 | WDR13 | WDR17 | WDR18 | WDR19 | WDR20 | WDR24 | WDR25 | WDR26 | WDR27 | WDR3 | WDR31 | WDR33 | WDR35 | WDR35-DT | WDR36 | WDR37 | WDR38 | WDR4 | WDR41 | WDR43 | WDR44 | WDR45 | WDR45B | WDR46 | WDR47 | WDR48 | WDR49 | WDR5 | WDR53 | WDR54 | WDR55 | WDR59 | WDR5B | WDR6 | WDR62 | WDR64 | WDR7 | WDR70 | WDR72 | WDR73 | WDR74 | WDR75 | WDR76